This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V4 | August 2025

Prescribing information and adverse event reporting statement can be found in the footer

This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V4 | August 2025

Prescribing information and adverse event reporting statement can be found in the footer

This educational and promotional event is organised and funded by Flynn Pharma Ltd. This meeting is intended for UK healthcare professionals.

Forensic Aspects of ADHD

Wednesday 3 December 2025 13:00 - 14:00
Register for our ADHD webinar where we will be focusing on challenges associated with identifying, managing, and treating ADHD within the forensic environment and to discuss the pharmacotherapy options available. Joined by Dr Rick Bunn, an expert in Forensic Psychiatry.
An account is required to register for this event.

Agenda

13:00
Welcome and Introductions, George Glenholmes, Engagement Specialist, Flynn Pharma Ltd
13:05
Forensic Aspects of ADHD, Dr Rick Bunn, Forensic Psychiatrist with special interest in ADHD, South Eastern Trust, Northern Ireland
13:50
Questions and Discussion
14:00
Meeting Close

Meet the Speakers

George Glenholmes
George Glenholmes
Engagement Specialist, Flynn Pharma Ltd
Dr Rick Bunn
Dr Rick Bunn
Forensic Psychiatrist with special interest in ADHD, South Eastern Trust, Northern Ireland

Dr Richard Bunn graduated from Queen’s University Belfast in 1997. He gained postgraduate qualifications in Child Health and Obstetrics & Gynaecology along with specialist training in Addictions and Forensic Psychiatry. He has been practising as a Consultant in Forensic Psychiatry since 2006 in Belfast and South Eastern Trusts. He also works for the Department of Health in Northern Ireland and has an interest in Adult ADHD.

What will the webinar cover?

Key learning objectives

  • To provide insights into the challenges associated with identifying, managing, and treating ADHD within the forensic environment.
  • To explore and discuss the pharmacotherapy options available to support clinicians in improving patient outcomes.